Cardiovascular risk, atherosclerosis and metabolic syndrome after liver transplantation: a mini review

References

• Desai S, Hong JC, Saab S. Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management. Liver Int. 30(7), 948–957 (2010).
   PubMed Web of Science ®Google Scholar
• Stravitz RT, Carl DE, Biskobing DM. Medical management of the liver transplant recipient. Clin. Liver Dis. 15(4), 821–843 (2011).
   PubMedGoogle Scholar
• Hanouneh IA, Feldstein AE, McCullough AJ et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl. 14(9), 1287–1293 (2008).
   PubMed Web of Science ®Google Scholar
• Albeldawi M, Aggarwal A, Madhwal S et al. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl. 18(3), 370–375 (2012).
   PubMedGoogle Scholar
• Watt KD, Charlton MR. Metabolic syndrome and liver transplantation: a review and guide to management. J. Hepatol. 53(1), 199–206 (2010).
   PubMed Web of Science ®Google Scholar
• Raval Z, Harinstein ME, Skaro AI et al. Cardiovascular risk assessment of the liver transplant candidate. J. Am. Coll. Cardiol. 58(3), 223–231 (2011).
   PubMedGoogle Scholar
• Pagadala M, Dasarathy S, Eghtesad B, McCullough AJ. Posttransplant metabolic syndrome: an epidemic waiting to happen. Liver Transpl. 15(12), 1662–1670 (2009).
   PubMed Web of Science ®Google Scholar
• Hryniewiecka E, Zegarska J, Paczek L. Arterial hypertension in liver transplant recipients. Transplant. Proc. 43(8), 3029–3034 (2011).
   PubMedGoogle Scholar
• Sheiner PA, Magliocca JF, Bodian CA et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 69(5), 781–789 (2000).
   PubMed Web of Science ®Google Scholar
• Munoz SJ, Deems RO, Moritz MJ, Martin P, Jarrell BE, Maddrey WC. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant. Proc. 23(1 Pt 2), 1480–1483 (1991).
   PubMedGoogle Scholar
• Everhart JE, Lombardero M, Lake JR, Wiesner RH, Zetterman RK, Hoofnagle JH. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl. Surg. 4(4), 285–296 (1998).
   PubMedGoogle Scholar
• Laryea M, Watt KD, Molinari M et al. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl. 13(8), 1109–1114 (2007).
   PubMed Web of Science ®Google Scholar
• Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl. 17(1), 15–22 (2011).
   PubMed Web of Science ®Google Scholar
• Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl. 18(1), 29–37 (2012).
   PubMed Web of Science ®Google Scholar
• Claes K, Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol. Dial. Transplant. 27(2), 850–857 (2012).
   PubMed Web of Science ®Google Scholar
• Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am. J. Transplant. 2(9), 807–818 (2002).
   PubMed Web of Science ®Google Scholar
• Muñoz SJ. Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: pathogenesis, diagnosis, and management. Liver Transpl. Surg. 1(5 Suppl. 1), 29–38 (1995).
   PubMedGoogle Scholar
• Rike AH, Mogilishetty G, Alloway RR et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin. Transplant. 22(2), 229–235 (2008).
   PubMedGoogle Scholar
• Segev DL, Sozio SM, Shin EJ et al. Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl. 14(4), 512–525 (2008).
   PubMed Web of Science ®Google Scholar
• Watt KD. Metabolic syndrome: is immunosuppression to blame? Liver Transpl. 17(Suppl. 3), S38–S42 (2011).
   PubMedGoogle Scholar
• Madhwal S, Atreja A, Albeldawi M et al. Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies. Liver Transpl. 18(10), 1140–1146 (2012).
   PubMedGoogle Scholar
• Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J. Am. Coll. Cardiol. 49(21), 2129–2138 (2007).
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 97(18), 1837–1847 (1998).
   PubMed Web of Science ®Google Scholar
• Alvares-da-Silva MR, Oliveira CP, Stefano JT et al. Conventional and novel cardiovascular risk factors in liver transplant recipients. J. Hepatol. 56(3), S75–S76 (2012).
   Google Scholar
• Oliveira CP, Kappel CR, Siqueira ER et al. Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int. J. Cardiol. 164(2), 221–226 (2013).
   PubMed Web of Science ®Google Scholar
• Coss E, Watt KD, Pedersen R, Dierkhising R, Heimbach JK, Charlton MR. Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl. 17(1), 23–31 (2011).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Balady GJ, Criqui MH et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 97(18), 1876–1887 (1998).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Merz CN et al.; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110(2), 227–239 (2004).
   PubMed Web of Science ®Google Scholar
• Newsome PN, Allison ME, Andrews PA et al.; British Transplant Society. Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis. Gut 61(4), 484–500 (2012).
   PubMedGoogle Scholar
• Anastácio LR, Ferreira LG, Ribeiro Hde S, Liboredo JC, Lima AS, Correia MI. Metabolic syndrome after liver transplantation: prevalence and predictive factors. Nutrition 27(9), 931–937 (2011).
   PubMedGoogle Scholar